0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

JAMA Oncology | 
Editorial |  FREE ONLINE FIRST
Kathleen R. Blazer, EdD, MS, LCGC; Thomas Slavin, MD; Jeffrey N. Weitzel, MD
JAMA Oncol. Published online February 11, 2016. doi:10.1001/jamaoncol.2015.5975

JAMA Oncology | 
Original Investigation |  FREE ONLINE FIRST
Shoshana M. Rosenberg, ScD, MPH; Kathryn J. Ruddy, MD, MPH; Rulla M. Tamimi, ScD; et al.
JAMA Oncol. Published online February 11, 2016. doi:10.1001/jamaoncol.2015.5941
Includes: Supplemental Content

JAMA Neurology | 
Original Investigation |  FREE ONLINE FIRST
Thaís Armangué, MD, PhD; Lidia Sabater, PhD; Estefanía Torres-Vega, BSc; et al.
JAMA Neurol. Published online February 08, 2016. doi:10.1001/jamaneurol.2015.4607
Includes: Supplemental Content

JAMA Oncology | 
Viewpoint | 
Teresa K. Woodruff, PhD; Kristin Smith, BS; William Gradishar, MD
JAMA Oncol. 2016;2(2):171-172. doi:10.1001/jamaoncol.2015.5609.

JAMA Oncology | 
From The JAMA Network | 
Heidi D. Nelson, MD, MPH
JAMA Oncol. 2016;2(2):261-262. doi:10.1001/jamaoncol.2015.4096.

JAMA Oncology | 
Invited Commentary | 
David Warr, MD, FRCPC; Carlo DeAngelis, PharmD; Edward Chow, MBBS
JAMA Oncol. 2016;2(2):232-233. doi:10.1001/jamaoncol.2015.3757.

JAMA Oncology | 
Original Investigation | 
Mark Clemons, MD; Nathaniel Bouganim, MD; Stephanie Smith, BA; et al.
JAMA Oncol. 2016;2(2):225-231. doi:10.1001/jamaoncol.2015.3730.
Includes: Supplemental Content

JAMA Oncology | 
From The JAMA Network | 
Michael LeBlanc, PhD; Catherine Tangen, DrPH
JAMA Oncol. 2016;2(2):263-264. doi:10.1001/jamaoncol.2015.4711.

JAMA Oncology | 
Editorial | 
Jee Ye Kim, MD; Seung-il Kim, MD, PhD; Soonmyung Paik, MD
JAMA Oncol. 2016;2(2):180-182. doi:10.1001/jamaoncol.2015.4343.

JAMA Oncology | 
Original Investigation | 
Shelli R. Kesler, PhD; Douglas W. Blayney, MD
JAMA Oncol. 2016;2(2):185-192. doi:10.1001/jamaoncol.2015.4333.
Includes: Supplemental Content

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Oncology
Editorial  | 
Increased Reach of Genetic Cancer Risk Assessment as a Tool for Precision Management of Hereditary Breast Cancer
Kathleen R. Blazer, EdD, MS, LCGC; Thomas Slavin, MD; Jeffrey N. Weitzel, MD
JAMA Oncology
Original Investigation  | 
BRCA1 and BRCA2 Mutation Testing in Young Women With Breast Cancer
Shoshana M. Rosenberg, ScD, MPH; Kathryn J. Ruddy, MD, MPH; Rulla M. Tamimi, ScD; et al.
JAMA Neurology
Original Investigation  | 
Clinical and Immunological Features of Opsoclonus-Myoclonus Syndrome in the Era of Neuronal Cell Surface Antibodies
Thaís Armangué, MD, PhD; Lidia Sabater, PhD; Estefanía Torres-Vega, BSc; et al.
JAMA Oncology
From The JAMA Network  | 
Mammography Screening and Overdiagnosis
Heidi D. Nelson, MD, MPH